Cargando…

Combination of Helicobacter pylori Antibody and Serum Pepsinogen as a Good Predictive Tool of Gastric Cancer Incidence: 20-Year Prospective Data From the Hisayama Study

BACKGROUND: There is little information regarding whether the combination of Helicobacter pylori (H. pylori) antibody and serum pepsinogen (sPG), which is a marker of the degree of atrophic gastritis, has a discriminatory ability for detecting incident gastric cancer. We examined this issue in a lon...

Descripción completa

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Epidemiological Association 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121431/ https://www.ncbi.nlm.nih.gov/pubmed/27265836 http://dx.doi.org/10.2188/jea.JE20150258

Ejemplares similares

Helicobacter pylori antibody and pepsinogen testing for predicting gastric microbiome abundance
por: Choi, Saemi, et al.
Publicado: (2019)

Gastric Cancer Screening by Combined Determination of Serum Helicobacter pylori Antibody and Pepsinogen Concentrations: ABC Method for Gastric Cancer Screening
por: Chen, Xian-Zhe, et al.
Publicado: (2018)

Endoscopic gastritis, serum pepsinogen assay, and Helicobacter pylori infection
por: Lee, Sun-Young
Publicado: (2016)

Long‐term Effect of Helicobacter pylori Infection on Serum Pepsinogens
por: Kikuchi, Shogo, et al.
Publicado: (2000)

Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels — “ABC method”
por: MIKI, Kazumasa
Publicado: (2011)

Receiver operating characteristic analysis of prediction for gastric cancer development using serum pepsinogen and Helicobacter pylori antibody tests
por: Hamashima, Chisato, et al.
Publicado: (2017)

Age-Specific Gastric Cancer Risk Indicated by the Combination of Helicobacter pylori Sero-Status and Serum Pepsinogen Levels
por: Eybpoosh, Sana, et al.
Publicado: (2015)

Helicobacter pylori Infection, Serum Pepsinogen Level and Gastric Cancer: A Case‐Control Study in Japan
por: Fukuda, Haruhiko, et al.
Publicado: (1995)

Optimal Criteria and Diagnostic Ability of Serum Pepsinogen Values for Helicobacter pylori Infection
por: Kikuchi, Shogo, et al.
Publicado: (2019)

Predicting the Development of Gastric Neoplasms in a Healthcare Cohort by Combining Helicobacter pylori Antibodies and Serum Pepsinogen: A 5-Year Longitudinal Study
por: Kwak, Min-Sun, et al.
Publicado: (2018)

Plasma pepsinogens, antibodies against Helicobacter pylori, and risk of gastric cancer in the Shanghai Women's Health Study Cohort
por: Abnet, C C, et al.
Publicado: (2011)

Sero-prevalence of Helicobacter pylori CagA immunoglobulin G antibody, serum pepsinogens and haemoglobin levels in adults
por: Muhsen, Khitam, et al.
Publicado: (2018)

Effect of Smoking on Serum Pepsinogen I Level Depends on Serological Status of Helicobacter pylori
por: Tatemichi, Masayuki, et al.
Publicado: (2001)

Prediction of true Helicobacter pylori-uninfected status using a combination of age, serum antibody and pepsinogen: Logistic regression analysis
por: Takayama, Takako, et al.
Publicado: (2020)

Serum Pepsinogen Values in Japanese Junior High School Students With Reference to Helicobacter Pylori Infection
por: Okuda, Masumi, et al.
Publicado: (2020)

Association of serum pepsinogens and gastrin-17 with Helicobacter pylori infection assessed by urea breath test
por: Zhou, Jun-peng, et al.
Publicado: (2022)

Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer
por: De Re, Valli, et al.
Publicado: (2016)

Helicobacter Pylori Infection and Serum Pepsinogen I Concentration in Peptic Ulcer Patients: Effect of Bacterial Eradication
por: Park, Sill Moo, et al.
Publicado: (1996)

Prediction of Gastric Cancer Development by Serum Pepsinogen Test and Helicobacter pylori Seropositivity in Eastern Asians: A Systematic Review and Meta-Analysis
por: Terasawa, Teruhiko, et al.
Publicado: (2014)

Role of Serum Pepsinogen II and Helicobacter pylori Status in the Detection of Diffuse-Type Early Gastric Cancer in Young Individuals in South Korea
por: Baek, Sung Min, et al.
Publicado: (2020)

Multicentric randomised study of Helicobacter pylori eradication and pepsinogen testing for prevention of gastric cancer mortality: the GISTAR study
por: Leja, Marcis, et al.
Publicado: (2017)

Serum pepsinogen II levels are doubled with Helicobacter pylori infection in an asymptomatic population of 40,383 Chinese subjects
por: Yu, Hong, et al.
Publicado: (2021)

Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high risk groups.
por: Knight, T., et al.
Publicado: (1996)

Helicobacter pylori infection, serum pepsinogens as markers of atrophic gastritis, and leukocyte telomere length: a population-based study
por: Muhsen, Khitam, et al.
Publicado: (2019)

Randomized Trial Comparing Esomeprazole and Rabeprazole in First-line Eradication Therapy for Helicobacter pylori Infection based on the Serum Levels of Pepsinogens
por: Shimoyama, Tadashi, et al.
Publicado: (2017)

Serum Pepsinogen Values and Helicobacter pylori Status among Control Subjects of a Nested Case-Control Study in the JACC study
por: Kikuchi, Shogo, et al.
Publicado: (2005)

Serum Helicobacter pylori FliD antibody and the risk of gastric cancer
por: Li, Hailin, et al.
Publicado: (2016)

Type I and type II Helicobacter pylori infection status and their impact on gastrin and pepsinogen level in a gastric cancer prevalent area
por: Yuan, Lin, et al.
Publicado: (2020)

Polymorphisms in Pepsinogen C and miRNA Genes Associate with High Serum Pepsinogen II in Gastric Cancer Patients
por: Re, Valli De, et al.
Publicado: (2021)

Association between Gastric Cancer Risk and Serum Helicobacter pylori Antibody Titers
por: Shuto, Mitsutaka, et al.
Publicado: (2017)

The Serum Pepsinogen Test as a Predictor of Kazakh Gastric Cancer
por: Juan Cai, Wei, et al.
Publicado: (2017)

Is serum pepsinogen testing necessary in populationbased screening for gastric cancer?
por: Kim, Yeon-Ji, et al.
Publicado: (2020)

Clinical value of serum pepsinogen in the diagnosis and treatment of gastric diseases
por: Qin, Yuan, et al.
Publicado: (2023)

Gastric neoplasms and pepsinogen phenotypes.
por: Ellis, A., et al.
Publicado: (1982)

A significant increase in the pepsinogen I/II ratio is a reliable biomarker for successful Helicobacter pylori eradication
por: Osumi, Hiroki, et al.
Publicado: (2017)

Clinical correlation between serum pepsinogen level and gastric atrophy in gastric neoplasm
por: Cha, Jae Hwang, et al.
Publicado: (2020)

Serum Helicobacter pylori NapA antibody as a potential biomarker for gastric cancer
por: Liu, Jingjing, et al.
Publicado: (2014)

Comparison of the serum and salivary antibodies to detect gastric Helicobacter pylori infection in Kashan (Iran)
por: Piroozmand, Ahmad, et al.
Publicado: (2017)

Association of serum pepsinogen with degree of gastric mucosal atrophy in an asymptomatic population
por: Cai, Hao-Lei, et al.
Publicado: (2021)

Helicobacter pylori Antibody Titer and Gastric Cancer Screening
por: Kishikawa, Hiroshi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lggd3i8g6ddc5up2je8eptbdrb